ES2095242T3 - Arilaminas y heteroarilaminas sustituidas, procedimiento para su preparacion y composiciones farmaceuticas que las contengan. - Google Patents

Arilaminas y heteroarilaminas sustituidas, procedimiento para su preparacion y composiciones farmaceuticas que las contengan.

Info

Publication number
ES2095242T3
ES2095242T3 ES90401850T ES90401850T ES2095242T3 ES 2095242 T3 ES2095242 T3 ES 2095242T3 ES 90401850 T ES90401850 T ES 90401850T ES 90401850 T ES90401850 T ES 90401850T ES 2095242 T3 ES2095242 T3 ES 2095242T3
Authority
ES
Spain
Prior art keywords
arylamines
pharmaceutical compositions
heteroarilamines
replaced
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90401850T
Other languages
English (en)
Inventor
Jean-Marc Kamenka
Alain Privat
Robert Rubin Chicheportiche
Jean Costentin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ipsen Pharma SAS
Original Assignee
Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS filed Critical Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Application granted granted Critical
Publication of ES2095242T3 publication Critical patent/ES2095242T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/033—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/58—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/08—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing alicyclic rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Psychiatry (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Quinoline Compounds (AREA)

Abstract

LA INVENCION SE REFIERE A ARILAMINAS Y HETEROARILAMINAS SUSTITUIDAS, AL PROCEDIMIENTO PARA SU OBTENCION Y A LA COMPOSICION FARMACEUTICA QUE LAS CONTIENE. ESTA AMINA SUSTITUIDA RESPONDE A LA FORMULA (I), EN LA QUE R1 Y R2 SON RADICALES ALQUILO EVENTUALMENTE SUSTITUIDOS O FORMAN CON N UN CICLO DE PIPERIDINA O PIPERAZINA EVENTUALMENTE SUSTITUIDA; R3 Y R4 REPRESENTAN UN ATOMO DE HIDROGENO O UN RADICAL ORGANICO; Y ES CR6 O N; Y R5 ES UN RADICAL BENZOTIOFENILO, BENZOFURANILO O NAFTILO EVENTUALMENTE SUSTITUIDO. ESTAS AMINAS SON UTILIZABLES EN COMPOSICIONES FARMACEUTICAS PARA EL TRATAMIENTO DE LA DEPRESION NERVIOSA O PARA LA ESTIMULACION DE LA VIGILANCIA.
ES90401850T 1989-06-29 1990-06-27 Arilaminas y heteroarilaminas sustituidas, procedimiento para su preparacion y composiciones farmaceuticas que las contengan. Expired - Lifetime ES2095242T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8908704A FR2649105B1 (fr) 1989-06-29 1989-06-29 Arylamines et heteroarylamines substituees, leur procede de preparation et composition pharmaceutique les contenant

Publications (1)

Publication Number Publication Date
ES2095242T3 true ES2095242T3 (es) 1997-02-16

Family

ID=9383267

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90401850T Expired - Lifetime ES2095242T3 (es) 1989-06-29 1990-06-27 Arilaminas y heteroarilaminas sustituidas, procedimiento para su preparacion y composiciones farmaceuticas que las contengan.

Country Status (7)

Country Link
EP (1) EP0406111B1 (es)
JP (1) JP3047112B2 (es)
AT (1) ATE143960T1 (es)
CA (1) CA2019622C (es)
DE (1) DE69028808T2 (es)
ES (1) ES2095242T3 (es)
FR (1) FR2649105B1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2763951B1 (fr) * 1997-06-03 2000-12-01 Sod Conseils Rech Applic Nouveaux derives de phencyclidines, des procedes pour leur preparation et des compositions pharmaceutiques les contenant
EP0986555A1 (fr) 1997-06-03 2000-03-22 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Nouveaux derives de phencyclidines, des procedes pour leur preparation et des compositions pharmaceutiques les contenant

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0317953A3 (en) * 1987-11-24 1990-12-05 G.D. Searle & Co. N-(1-thienylcycloalkyl)alkenylamines for treatment of neurotoxic injury

Also Published As

Publication number Publication date
EP0406111B1 (fr) 1996-10-09
CA2019622C (en) 2002-01-08
EP0406111A1 (fr) 1991-01-02
JP3047112B2 (ja) 2000-05-29
DE69028808D1 (de) 1996-11-14
FR2649105A1 (fr) 1991-01-04
ATE143960T1 (de) 1996-10-15
CA2019622A1 (en) 1990-12-29
DE69028808T2 (de) 1997-04-30
JPH0344356A (ja) 1991-02-26
FR2649105B1 (fr) 1994-04-29

Similar Documents

Publication Publication Date Title
DK139287A (da) Tertiaere hydroxyalkylxanthiner, deres fremstilling og anvendelse som laegemidler
DK716188D0 (da) Quinoxalinforbindelser, deres fremstilling og anvendelse
DE60033566D1 (de) Neue sertralinhydrochlorid polymorphe, verfahren zur herstellung und zur verwendung und diese enthaltende zusammensetzungen
DK715888D0 (da) Quinoxalinforbindelser, deres fremstilling og anvendelse
FI894061A0 (fi) Menetelmä lääkeaineina käyttökelpoisten , -disubstituoitujen N-sykloalkyylialkyylibentsyyliamiinien valmistamiseksi ja niiden synteesivälituotteita
ATE2265T1 (de) Sekundaere amine, ihre herstellung und verwendung in pharmazeutischen zusammensetzungen.
PT71644A (de) Verfahren zur herstellung von 4-phenoxypiperidinen
DE3064835D1 (en) 2-hydroxyalkyl-3,4,5,trihydroxy piperidines, processes for their preparation and their use as medicaments
PT93360A (pt) Processo para a preparacao de n-(1,4-benzo-diazepin-3-il)amidas de acidos 1h-indol-2-carboxilicos condensados nas posicoes 1,7 e de composicoes farmaceuticas que as contem
DE3267429D1 (en) 1-phenyl-2-aminocarbonylindole compounds, process and intermediates for their preparation and medicines containing them
ES2046671T3 (es) Un procedimiento para la preparacion de tetrahidroimidazo(1,4)benzodiazepin-2-tionas.
ES2095242T3 (es) Arilaminas y heteroarilaminas sustituidas, procedimiento para su preparacion y composiciones farmaceuticas que las contengan.
PT96164A (pt) Processo de preparacao de uma composicao farmaceutica a base de derivados de fluoroquinolona
ES533378A0 (es) Procedimiento para la preparacion de derivados de b-carbolinas.
ES527091A0 (es) Procedimiento para la fabricacion de la piperidindiona protectora del miocardio, con actividad antiarritmica
SE8501613D0 (sv) Foreningar for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutisk behandling
NO923653D0 (no) Imidazolylpyridinderivater
ES2038216T3 (es) Procedimiento para la preparacion de 5-(3-alquil-5-t-butil-4-hidroxi-fenil)-2-amino-6h-1,3,4-tiadazinas y su empleo.
FR2646349B1 (fr) Derives du 4-phenylmethyl lh-indole, procede et intermediaires de preparation, application a titre de medicaments et compositions les renfermant
ES529007A0 (es) Procedimiento para la fabricacion de derivados aminados de la piridazina substituidos en posicion 6 por un heterociclo o un aliciclo, activos sobre el sistema nervioso central.
ES2108691T3 (es) Compuestos y composiciones absorbentes de uv.
PT83975B (pt) Processo para a preparacao de derivados de 5-aminoalquil-beta-carbolinas e de composicoes farmaceuticas que os contem
GR3000969T3 (en) Alkyl carboxamides of pyridyl alkyl amines, their preparation and their use as medicaments
DE69122480D1 (de) Verwendung von Phenyläthanolaminotetralinen zur Herstellung eines antidepressiven und Antistress-Arzneimittels
ATE71936T1 (de) 1-styrensulfonyl-2-oxo-5-hydroxy-pyrrolidine, ihre vorprodukte und verfahren zur herstellung, sie enthaltende zusammensetzungen und ihre anwendung als heilmittel.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 406111

Country of ref document: ES